AGO2 and cancer: Few CAV1 proteins were coprecipitated with Ago2 in both A549 and HCC1806 cancer cells treated with P2 peptides, suggesting that Ago2/CAV1 interaction in cancer cells was interrupted by the P2 peptide (Figs. EV2B,, C).